The changing landscape of automated insulin delivery in the management of type 1 diabetes
Automated insulin delivery systems, also known as closed-loop o r ‘artificial pancreas’ systems, are transforming the management of type 1 diabetes. These systems consist of an algorithm which responds to real-time glucose sensor levels by automatically modulating insulin delivery through an insulin...
Main Authors: | Rama Lakshman, Charlotte Boughton, Roman Hovorka |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-08-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/12/8/EC-23-0132.xml |
Similar Items
-
Open source automated insulin delivery systems: experience of russian patients
by: V. V. Klimontov, et al.
Published: (2023-12-01) -
Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol
by: Kaat Beunen, et al.
Published: (2023-03-01) -
Open source automated insulin delivery systems: benefits, limitations and challenges in diabetes care
by: K. S. Shishin, et al.
Published: (2023-08-01) -
Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
by: Julia Fuchs, et al.
Published: (2021-04-01) -
Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023
by: Marta Bassi, et al.
Published: (2023-03-01)